Pain management with opioid, non-opioid, and non-pharmacological interventions
New Course Now Available!
Use and abuse of opioid has been a leading topic in the national news for several years. Education, training and the use of Naloxone are beginning to help change the trajectory of the epidemic of abuse. Further awareness and open discussions in the medical profession continue to be necessary to further protect our society from themselves.
Subject Matter Experts
The Opidemic: Our Role in Curbing this Devastation is approved for CME. A minimum of 3.5 hours must be completed for a certificate. The core 3.0 hour course consists of units 1-6, with an additional half hour coming from at least one of the six elective hour courses. For controlled substance prescribers, you must claim CME credit at the end of the course to receive the DOPL required certificate of completion.
Other learners need to check with their regulatory groups regarding allowed credit.
Requirements for training for Medication Assistant Treatment as part of the MATE Act
On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all DEA registered practitioners on the treatment and management of patients with opioid or other substance use disorders. After June 27, 2023, practitioners will be required to check a box on their online DEA registration form (for both initial registration application and renewing registration) affirming that they have completed the new training requirement.
For our Utah practitioners, if you have completed the DOPL Controlled Substances (3.5+ hours) training at least 2 times previously, then you have already met this requirement. If you have attended any UU internal CME events in the past, such as Grand Rounds or Tumor Boards (TPC) where management of patients with opioid or other substance use disorders have been discussed for a total of 8 hours of credits, then you have already met this requirement.
If you feel that you have not met this requirement, or if you would like additional training, you can complete the University of Utah online Opioid Education for Utah Licensed Practitioners (which has a maximum of 8 hours of credit available) and the Screening, Brief Intervention, and Referral to Treatment (SBIRT) modules, which will meet the new requirements here: https://substanceei.com/
SBIRT is required for Utah controlled substance prescribers at some point, once, before their 2026 license renewal, per Utah DOPL regulations. So if you have completed the previous opioid training, you will still need to complete SBIRT before your next license renewal for the 2026 cycle.
The instructional content has been designed to comply with the Utah licensing opioid education requirement.
The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Utah School of Medicine designates this enduring activity for a maximum of 8.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Speaker and Planning Committee Disclosure Summary:
The University of Utah School of Medicine Continuing Medical Education Office (UUCME) meets ACCME Standards for Integrity and Independence expectations regarding the identification and mitigation of relevant financial relationships with ACCME-defined ineligible companies. Everyone in control of content, including all speakers and planners, must disclose financial relationships in any amount within the past 24 months and any relevant financial relationships must be mitigated prior to the activity start.
Neither the speaker(s), planner(s), nor anyone in control of content for this enduring activity have any financial relationship with commercial products or services discussed today the exception of Marcela Smid, who is a PI/research grant from Gilead Science Inc, a consultant for Organon and Rhia Ventures and Scott Junkins, single session Advisory Board for Roche/Genentech. All relevant financial relationships have been mitigated.
NONDISCRIMINATION AND DISABILITY ACCOMMODATION STATEMENT:
The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, ethnicity, sex, disability, age, veteran’s status, religion, gender identity, gender expression, pregnancy or pregnancy-related conditions, genetic information, or sexual orientation in admission to or participation in its programs and activities. Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice. Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 383 University Street, Level One OEO Suite, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).
MOC Part II
Need all Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
- 08.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and
- 08.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; and
- 08.00 MOC points in the American Board of Otolaryngology Head and Neck Surgery Continuing Certification Lifelong Learning and Self-Assessment (ABOHNS) Maintenance of Certification (MOC part II) and enables the participant to earn their required annual part II self‐ assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). ; and
- 08.00 MOC Points in the American Board of Pathology Lifelong Learning (ABPath) and enables the participant to earn up to 1.0 Lifelong Learning (CME) credit in the American Board of Pathology (ABPath) Continuing Certification program.; and
- 08.00 MOC Points in the American Board of Anesthesiology (ABA) Successful completion of this CME activity enables the participant to earn up to 8.00 MOCA 2.0® points in the American Board of Anesthesiology® Maintenance of Certification in Anesthesiology Program®. Maintenance of Certification in Anesthesiology Program® and MOCA® are registered certification marks of the American Board of Anesthesiology®. MOCA 2.0® is a trademark of the American Board of Anesthesiology®
- Successful completion of this CME activity, enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program (ABS/CC).
- Successful completion of this CME activity, enables the learner to earn credit toward the CME of the American Board of Thoracic Surgery’s Maintenance of Certification program (ABTS).
- Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Orthopaedic Surgery’s Maintenance of Certification program (ABOS).
It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM, ABP, ABA, ABOHNS, ABTS, ABS/CC, ABOS and ABPath MOC Part II credits. If you provide your ABMS board, diplomate ID, birthday, and permission to share data at registration, when you complete the course, UUCME will report your MOC part II credit to the board for you. We do this through ACCME for the following boards ABIM, ABP, ABA, ABOHNS, ABS/ CC, ABTS, ABOS and ABPath MOC Part II credits
All attendees are encouraged to use the CME system to claim their attendance. Physicians will be awarded AMA PRA Category 1TM credits; all other professions will be awarded attendance at a CME event credit that they may use for their re-credentialing purposes. All users will be able to print or save certificates.